These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6697360)

  • 41. The concentration of lipids, lipoproteins and apolipoproteins in cord blood serum of newborns in the course of intrauterine period.
    Pac-Kozuchowska E
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):25-32. PubMed ID: 15323161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The 6th international conference on atherosclerosis].
    Chen HZ
    Zhonghua Yi Xue Za Zhi; 1983 Mar; 63(3):179-81. PubMed ID: 6409384
    [No Abstract]   [Full Text] [Related]  

  • 43. [Recognition of the preclinical period of atherosclerosis].
    Il'inskiĭ BV
    Klin Med (Mosk); 1965 Sep; 43(9):29-35. PubMed ID: 5870046
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical and pharmacological aspects of atherosclerosis in middle and old age].
    Kovalenko AN
    Feldsher Akush; 1986 Nov; 51(11):32-7. PubMed ID: 3646112
    [No Abstract]   [Full Text] [Related]  

  • 45. Genetic susceptibility to atherosclerosis.
    Breslow JL; Deeb S; Lalouel JM; Le Boeuf R; Schaefer EJ; Tyroler HA; Wilson P; Young S
    Circulation; 1989 Sep; 80(3):724-8. PubMed ID: 2670322
    [No Abstract]   [Full Text] [Related]  

  • 46. [Apolipoproteins: physiology and clinical importance].
    Farhy R; Caeiro T; Achával A
    Medicina (B Aires); 1989; 49(6):631-2. PubMed ID: 2487438
    [No Abstract]   [Full Text] [Related]  

  • 47. Biochemical studies in relation to comparative susceptibility to experimental atherosclerosis.
    PILGERAM LO
    Fed Proc; 1955 Sep; 14(3):728-32. PubMed ID: 13262134
    [No Abstract]   [Full Text] [Related]  

  • 48. Mast cells and susceptibility to experimental atherosclerosis.
    CONSTANTINIDES P
    Science; 1953 May; 117(3045):505-6. PubMed ID: 13056595
    [No Abstract]   [Full Text] [Related]  

  • 49. Steenbock symposium on molecular biology of atherosclerosis.
    Attie AD
    Arterioscler Thromb; 1991; 11(1):204-9. PubMed ID: 1988000
    [No Abstract]   [Full Text] [Related]  

  • 50. Genetics and atherosclerosis: broadening the horizon.
    Humphries SE; Ordovas JM
    Atherosclerosis; 2001 Feb; 154(3):517-9. PubMed ID: 11257251
    [No Abstract]   [Full Text] [Related]  

  • 51. [Apolipoproteins in the evaluation of familial susceptibility to atherosclerosis].
    Jirkovská A; Válek J; Grafnetter D; Vondra K; Skibová J
    Cas Lek Cesk; 1984 Feb; 123(5):130-2. PubMed ID: 6697360
    [No Abstract]   [Full Text] [Related]  

  • 52. New aspects in lipidology and atherosclerosis.
    Superko HR
    Can J Cardiol; 1995 May; 11 Suppl C():4C-8C. PubMed ID: 7750049
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The relationship of apoB gene polymorphism to dyslipoproteinemia as the cause of atherosclerosis].
    Kravchenko NA
    Tsitol Genet; 1995; 29(4):84-7. PubMed ID: 8604528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Genetics of atherosclerosis and its clinical manifestations].
    Davidenkova EF; Kolosova NN; Liberman IS; Shafran MG
    Klin Med (Mosk); 1986 Feb; 64(2):9-14. PubMed ID: 3517481
    [No Abstract]   [Full Text] [Related]  

  • 55. [The determination of apolipoproteins. Its possible diagnostic importance].
    Titov VN; Tvorogova MG
    Ter Arkh; 1992; 64(6):115-9. PubMed ID: 1440326
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.